Fields »
ABOUT
HELP
BLOG

116 GENES FOUND

Show / hide columns

XML | RDF | TSV | Page of 3 | next »

Gene

 

 

Gene description

x

 

 

 

 

 

 

 

Tissue

Cell

Pathology

 

 

 

 

IH abundance (Normal Tissue)

x

RNA abundance (Normal Tissue)

x

Subcellular location

x

Prognostic p-value

x

 

RNA tissue category

x

RNA TS

x

RNA TS TPM

x

 

 

 

 

 

 

 

 

 

 

 

 

 

 
ABCA5ATP-binding cassette, sub-family A (ABC1), member 5
Pancreatic cancer: 9.97e-5
Expressed in all
ABCB6ATP-binding cassette, sub-family B (MDR/TAP), member 6 (Langereis blood group)
Nucleoplasm
Golgi apparatus
Plasma membrane
Mitochondria
Cytosol		Renal cancer: 1.52e-7
Liver cancer: 9.45e-7
Expressed in all
ABCC12ATP-binding cassette, sub-family C (CFTR/MRP), member 12N/A
Tissue enhancedtestis:2.9
ABCC4ATP-binding cassette, sub-family C (CFTR/MRP), member 4
Nucleoli
Plasma membrane
Cytosol		Renal cancer: 2.25e-10
Endometrial cancer: 9.89e-4
Tissue enhancedprostate:68.5
ALG3ALG3, alpha-1,3- mannosyltransferase
Liver cancer: 1.58e-5
Lung cancer: 8.67e-5
Renal cancer: 1.25e-4
Expressed in all
ANKHANKH inorganic pyrophosphate transport regulator
CytosolGlioma: 7.64e-4
Expressed in all
ANO3Anoctamin 3
Tissue enriched6epididymis:61.3
ANO4Anoctamin 4N/A
Renal cancer: 5.48e-5
Group enriched6adrenal gland:17.6
cerebral cortex:10.0
cervix, uterine:12.5
endometrium:8.3
ovary:10.9
prostate:10.9
seminal vesicle:11.3
ANO5Anoctamin 5
Renal cancer: 2.50e-7
Tissue enhancedparathyroid gland:55.2
ANO6Anoctamin 6
Plasma membrane
Cytosol		Breast cancer: 7.56e-5
Cervical cancer: 3.82e-4
Expressed in all
ANO7Anoctamin 7
Tissue enhancedprostate:86.9
stomach:26.2
ANO9Anoctamin 9
Golgi apparatusUrothelial cancer: 8.81e-4
Tissue enhancedduodenum:32.4
small intestine:31.6
ATP13A2ATPase type 13A2
Liver cancer: 3.33e-7
Expressed in all
ATP13A4ATPase type 13A4
NucleoplasmHead and neck cancer: 3.91e-4
Tissue enhancedepididymis:89.1
parathyroid gland:129.5
thyroid gland:68.2
ATP2A2ATPase, Ca++ transporting, cardiac muscle, slow twitch 2
NucleoplasmExpressed in all
ATP2B2ATPase, Ca++ transporting, plasma membrane 2
Tissue enriched7cerebral cortex:63.0
ATP2C1ATPase, Ca++ transporting, type 2C, member 1
Golgi apparatusLiver cancer: 5.06e-6
Pancreatic cancer: 1.52e-4
Renal cancer: 1.55e-4
Expressed in all
ATP7BATPase, Cu++ transporting, beta polypeptide
Golgi apparatusEndometrial cancer: 5.01e-4
Mixed
CDS1CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1
Nucleus
Nuclear membrane		Renal cancer: 0.00e+0
Colorectal cancer: 5.22e-4
Mixed
CDS2CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2
Endoplasmic reticulum
Cytosol		Renal cancer: 3.53e-9
Expressed in all
CLN3Ceroid-lipofuscinosis, neuronal 3
Expressed in all
ERMP1Endoplasmic reticulum metallopeptidase 1
Nucleus
Nucleoli		Renal cancer: 5.83e-10
Tissue enhancedparathyroid gland:122.3
G6PC3Glucose 6 phosphatase, catalytic, 3
Endoplasmic reticulumEndometrial cancer: 1.11e-4
Liver cancer: 9.61e-4
Expressed in all
GPR89AG protein-coupled receptor 89A
Endoplasmic reticulumMixed
GPR89BG protein-coupled receptor 89B
Endoplasmic reticulumExpressed in all
HM13Histocompatibility (minor) 13
Endoplasmic reticulumRenal cancer: 4.64e-12
Liver cancer: 1.95e-5
Expressed in all
LBRLamin B receptor
Nuclear membraneLiver cancer: 7.30e-4
Expressed in all
LMBR1Limb development membrane protein 1
CytosolRenal cancer: 1.44e-6
Expressed in all
LMBRD1LMBR1 domain containing 1
Renal cancer: 1.07e-7
Expressed in all
LMBRD2LMBR1 domain containing 2
Nucleoplasm
Cytosol		Expressed in all
LMF2Lipase maturation factor 2
CentrosomeCervical cancer: 3.47e-4
Expressed in all
MBOAT2Membrane bound O-acyltransferase domain containing 2
VesiclesEndometrial cancer: 2.13e-9
Urothelial cancer: 5.32e-4
Tissue enhancedparathyroid gland:49.4
MFSD5Major facilitator superfamily domain containing 5
Liver cancer: 1.43e-6
Expressed in all
MFSD9Major facilitator superfamily domain containing 9
NucleoliGlioma: 7.48e-4
Mixed
MT-CYBMitochondrially encoded cytochrome b
MitochondriaLiver cancer: 5.96e-4
Expressed in all
NIPA1Non imprinted in Prader-Willi/Angelman syndrome 1
Tissue enhancedcerebral cortex:38.3
NIPA2Non imprinted in Prader-Willi/Angelman syndrome 2
Golgi apparatusExpressed in all
NIPAL1NIPA-like domain containing 1
Golgi apparatusTissue enhancedesophagus:24.2
skin:31.0
NIPAL2NIPA-like domain containing 2
Mixed
NIPAL3NIPA-like domain containing 3
NucleoplasmRenal cancer: 3.03e-7
Thyroid cancer: 3.95e-4
Expressed in all
NIPAL4NIPA-like domain containing 4
Urothelial cancer: 6.82e-4
Tissue enhancedskin:42.0
PCNXL2Pecanex-like 2 (Drosophila)
Endoplasmic reticulumRenal cancer: 2.27e-5
Mixed
POMT1Protein-O-mannosyltransferase 1
Golgi apparatusPancreatic cancer: 3.90e-5
Renal cancer: 4.68e-5
Expressed in all
PORCNPorcupine homolog (Drosophila)
VesiclesMixed
PTDSS1Phosphatidylserine synthase 1N/A
Nucleoplasm
Endoplasmic reticulum		Liver cancer: 1.08e-5
Lung cancer: 9.83e-4
Mixed
PTDSS2Phosphatidylserine synthase 2
Liver cancer: 5.12e-9
Expressed in all
RP11-468E2.1
Golgi apparatusExpressed in all
SCN7ASodium channel, voltage gated, type VII alpha subunitN/A
Tissue enhancedovary:63.0
SEC61A1Sec61 translocon alpha 1 subunit
Endoplasmic reticulumRenal cancer: 6.84e-9
Liver cancer: 1.07e-6
Endometrial cancer: 7.82e-4
Expressed in all
SERINC5Serine incorporator 5
Nucleus
Golgi apparatus
Vesicles		Mixed

Page of 3 | next »

Contact

The Project

The Human Protein Atlas

The Human Protein Atlas project is funded
by the Knut & Alice Wallenberg foundation.